Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 2938116)

Published in Mol Cell Proteomics on May 25, 2010

Authors

Tzu-Hao Wang1, Angel Chao, Chia-Lung Tsai, Chih-Long Chang, Shun-Hua Chen, Yun-Shien Lee, Jen-Kun Chen, Yi-Jun Lin, Pi-Yueh Chang, Chin-Jung Wang, An-Shine Chao, Shuenn-Dyh Chang, Ting-Chang Chang, Chyong-Huey Lai, Hsin-Shih Wang

Author Affiliations

1: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Tao-Yuan, Taiwan. knoxtn@cgmh.org.tw

Articles citing this

Identification of cell membrane protein stress-induced phosphoprotein 1 as a potential ovarian cancer biomarker using aptamers selected by cell systematic evolution of ligands by exponential enrichment. Anal Chem (2014) 0.97

Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation. Cell Death Dis (2014) 0.92

Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One (2013) 0.87

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma. PLoS One (2013) 0.86

Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα). PLoS One (2013) 0.85

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A (2016) 0.83

Grading breast cancer tissues using molecular portraits. Mol Cell Proteomics (2013) 0.82

Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival. Oncogene (2014) 0.80

Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications. Front Oncol (2015) 0.79

Comparative proteomics analysis of oral cancer cell lines: identification of cancer associated proteins. Proteome Sci (2014) 0.79

Regulation of stress-inducible phosphoprotein 1 nuclear retention by protein inhibitor of activated STAT PIAS1. Mol Cell Proteomics (2013) 0.77

Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages. J Neuroimmunol (2014) 0.77

Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo. Cancer Sci (2016) 0.76

BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer. PLoS One (2015) 0.76

Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells. Clin Exp Metastasis (2016) 0.76

Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Tumour Biol (2015) 0.76

Hyperactivity and attention deficits in mice with decreased levels of stress-inducible phosphoprotein 1 (STIP1). Dis Model Mech (2015) 0.75

HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature. Cell Stress Chaperones (2016) 0.75

Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells. Oncotarget (2016) 0.75

The levels of serine proteases in colon tissue interstitial fluid and serum serve as an indicator of colorectal cancer progression. Oncotarget (2016) 0.75

Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma. Oncotarget (2017) 0.75

Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells. Oncotarget (2016) 0.75

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Front Neurosci (2017) 0.75

Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells. Oncol Lett (2017) 0.75

Articles cited by this

Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89

Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci (2001) 6.61

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod (1989) 4.13

Mining the plasma proteome for cancer biomarkers. Nature (2008) 4.10

Disease proteomics. Nature (2003) 3.36

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem (2003) 3.30

Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem (2001) 2.85

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer (2006) 2.70

Clinical practice. Screening for ovarian cancer. N Engl J Med (2009) 2.50

Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci (2007) 2.01

Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem (1998) 1.93

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer (2002) 1.80

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics (2007) 1.57

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics (2004) 1.57

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment. Cancer Lett (2007) 1.46

Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem (1999) 1.41

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics (2007) 1.39

Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics (2006) 1.30

Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays (2004) 1.30

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer Lett (2006) 1.25

Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst (2007) 1.22

Prion protein expression in human leukocyte differentiation. Blood (1998) 1.21

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer (2006) 1.11

In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. Cancer Res (2009) 1.08

Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril (2006) 1.06

The expression and potential function of cellular prion protein in human lymphocytes. Cell Immunol (2001) 1.04

Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene (2006) 1.03

STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia (2007) 1.02

Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. J Cell Sci (2004) 1.02

Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res (2005) 0.97

Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci (2008) 0.96

Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci (2009) 0.93

Diagnostic tests: a statistical review. Muscle Nerve (1994) 0.90

Towards discovery-driven translational research in breast cancer. FEBS J (2005) 0.90

HUPO initiatives relevant to clinical proteomics. Mol Cell Proteomics (2004) 0.88

Genomic tests for ovarian cancer detection and management. Evid Rep Technol Assess (Full Rep) (2006) 0.88

Hop cleavage and function in granzyme B-induced apoptosis. J Biol Chem (2006) 0.86

Signaling induced by hop/STI-1 depends on endocytosis. Biochem Biophys Res Commun (2007) 0.80

Clinical proteomics. Mol Cell Proteomics (2008) 0.77

Articles by these authors

Assessing the potential exposure risk and control for airborne titanium dioxide and carbon black nanoparticles in the workplace. Environ Sci Pollut Res Int (2011) 2.69

Autophagic machinery activated by dengue virus enhances virus replication. Virology (2008) 2.23

The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res (2005) 2.21

A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol (2004) 2.10

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol (2012) 2.03

The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol (2006) 1.93

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A (2002) 1.92

Highly efficient classification and identification of human pathogenic bacteria by MALDI-TOF MS. Mol Cell Proteomics (2007) 1.73

Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol (2003) 1.72

MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol (2006) 1.63

Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg (2006) 1.61

Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med (2004) 1.58

Type I interferons protect mice against enterovirus 71 infection. J Gen Virol (2005) 1.57

Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilization-embryo transfer. Fertil Steril (2003) 1.56

Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.55

Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP syndrome and women with severe pre-eclampsia without HELLP. J Obstet Gynaecol Res (2006) 1.50

Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation. Heart Rhythm (2012) 1.47

Laparoscopic myomectomy. Taiwan J Obstet Gynecol (2009) 1.46

Management of port-site metastasis after laparoscopic surgery for ovarian cancer. Am J Obstet Gynecol (2003) 1.45

Trocar-assisted sling suspension for stress urinary incontinence. J Am Assoc Gynecol Laparosc (2002) 1.42

Transient chorioamniotic membrane separation after fetoscope guide laser therapy for twin-twin transfusion syndrome: a case report. Fetal Diagn Ther (2007) 1.40

Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol (2002) 1.40

Is conization once following by simple hysterectomy sufficient for all clinical stage IA1 cervical squamous cell carcinoma? Taiwan J Obstet Gynecol (2013) 1.39

Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol (2003) 1.31

Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol (2005) 1.26

Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25

Fabrication of one-transistor-capacitor structure of nonvolatile TFT ferroelectric RAM devices using Ba(Zr0.1Ti0.9)O3 gated oxide film. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 1.25

Psychiatric morbidity and pregnancy outcome in a disaster area of Taiwan 921 earthquake. Psychiatry Clin Neurosci (2002) 1.24

Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol (2006) 1.24

Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol (2009) 1.23

Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res (2002) 1.21

Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells (2007) 1.20

Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res (2007) 1.20

Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis (2008) 1.19

Risk analysis of torsion and malignancy for adnexal masses during pregnancy. Fertil Steril (2008) 1.19

Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging (2008) 1.19

Endoscopic management of cesarean scar pregnancy. Fertil Steril (2006) 1.14

Sclerosing stromal tumor of ovary. Chang Gung Med J (2003) 1.14

Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J Immunol (2009) 1.13

Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation. J Biol Chem (2010) 1.13

Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health (2012) 1.13

Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging (2008) 1.13

Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study. Eur J Cancer (2012) 1.12

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer (2006) 1.11

18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med (2004) 1.11

Space electric field concentrated effect for Zr:SiO2 RRAM devices using porous SiO2 buffer layer. Nanoscale Res Lett (2013) 1.11

Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis. Medicine (Baltimore) (2016) 1.11

Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett (2009) 1.10

Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol (2007) 1.10

Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) (2009) 1.10

Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol (2005) 1.09

Fas ligand on tumor cells mediates inactivation of neutrophils. J Immunol (2003) 1.06

Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril (2006) 1.06

Congenital mixed malignant germ cell tumor involving cerebrum and orbit. J Perinat Med (2003) 1.06

Transurethral partial cystectomy and laparoscopic reconstruction for the management of bladder endometriosis. Fertil Steril (2008) 1.05

Caesarean scar pregnancy successfully treated by operative hysteroscopy and suction curettage. BJOG (2005) 1.05

Microarray meta-analysis database (M(2)DB): a uniformly pre-processed, quality controlled, and manually curated human clinical microarray database. BMC Bioinformatics (2010) 1.05

18F-FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging (2005) 1.04

Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency. J Virol (2003) 1.04

Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab (2002) 1.04

Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol (2004) 1.03

Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol (2006) 1.03

Systematic assessment of the tagging polymorphisms of the COL1A1 gene for high myopia. J Hum Genet (2007) 1.03

Segmentation of cDNA microarray images by kernel density estimation. J Biomed Inform (2008) 1.03

Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer (2002) 1.03

Inactivation of viruses by coherent excitations with a low power visible femtosecond laser. Virol J (2007) 1.02

Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol (2003) 1.01

Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res (2005) 1.01

Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res (2008) 1.01

Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.00

A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. J Biomed Sci (2006) 1.00